Oncology Information Systems Market Size, Share & Analysis Report, 2024-2033
The global oncology information systems market size was estimated at USD 8.45 billion in 2023 and is projected to hit around USD 17.75 billion by 2033, growing at a CAGR of 7.7% during the forecast period from 2024 to 2033.
The Oncology Information Systems (OIS) market represents a critical and evolving sector in healthcare IT, providing specialized software solutions designed to manage, coordinate, and optimize the clinical, administrative, and financial workflows associated with cancer care. Oncology, as one of the most complex therapeutic areas, requires seamless integration of multi-disciplinary care processes including diagnosis, treatment planning, therapeutic administration, follow-up, and survivorship care.
OIS solutions enable healthcare providers to collect, organize, and analyze large volumes of oncology-specific patient data, including imaging, pathology, genetic profiles, treatment regimens, and outcomes. By facilitating evidence-based decision-making and enhancing care coordination, OIS platforms play a pivotal role in improving patient outcomes, ensuring regulatory compliance, and optimizing operational efficiency.
The growing global burden of cancer, the increasing adoption of electronic health records (EHR), advancements in precision medicine, and rising demand for personalized cancer therapies are driving the need for sophisticated information management systems in oncology. Moreover, the COVID-19 pandemic underscored the importance of digitalization in healthcare delivery, further accelerating investments in oncology information systems.
Major players are investing heavily in cloud-based OIS solutions, AI integration for decision support, interoperability standards, and patient-centric modules to meet the dynamic needs of modern cancer care. As healthcare systems globally pivot towards value-based models and personalized medicine, the Oncology Information Systems market is poised for robust growth over the coming decade.
Adoption of Cloud-Based Oncology Information Systems: Increasing preference for cloud-hosted solutions offering scalability, remote access, and enhanced data security.
Integration of Artificial Intelligence and Machine Learning: AI-driven decision support tools are improving diagnostic accuracy, treatment planning, and predictive analytics in oncology care.
Emphasis on Interoperability: Growing demand for OIS platforms that seamlessly integrate with Electronic Health Records (EHR), Radiology Information Systems (RIS), and Laboratory Information Systems (LIS).
Expansion of Precision Medicine Initiatives: OIS systems are evolving to support genomics, biomarker-driven therapies, and personalized treatment regimens.
Patient Engagement Tools: Development of patient portals and mobile apps linked to OIS platforms to empower patients in managing appointments, accessing treatment plans, and monitoring side effects.
Focus on Data Analytics for Population Health Management: Utilization of aggregated oncology data to drive research, improve care quality, and support healthcare policymaking.
Rise of Remote Monitoring and Teleoncology: Enabling virtual consultations, remote treatment monitoring, and decentralized clinical trials for oncology patients.
Growing Investments in Cancer Centers and Specialty Clinics: Increasing establishment of dedicated oncology care centers, creating strong demand for integrated information management systems.
| Report Attribute | Details |
| Market Size in 2024 | USD 9.11 Billion |
| Market Size by 2033 |
USD 17.75 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 7.7% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product & services, application, end-user, region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Elekta AB; Accuray Inc.; Varian Medical Systems; RaySearch Laboratories; Cerner Corp.; BrainLab; Philips Healthcare; Prowess, Inc.; DOSIsoft S.A.; ViewRay Inc.; MIM Software and Flatiron, McKesson Corporation, Siemens Medical Solutions Inc. |
The Solutions segment dominated the Oncology Information Systems market, encompassing comprehensive platforms for patient information management, treatment planning, and clinical decision support. These software solutions facilitate the end-to-end management of oncology workflows, including diagnostics, radiation therapy, chemotherapy administration, and patient follow-up. Integrated platforms such as Elekta’s MOSAIQ and Varian’s ARIA OIS are widely adopted due to their ability to consolidate patient data across multiple specialties, enabling multidisciplinary teams to collaborate effectively.
Solutions offer scalability, flexibility, and enhanced reporting capabilities, making them highly valuable for both large hospital networks and specialized cancer centers. Their role in supporting clinical trials, meeting accreditation standards (e.g., from the American College of Radiology), and improving treatment adherence further strengthens their market leadership.
Meanwhile, the Professional Services segment is expected to grow at the fastest pace. As oncology care becomes increasingly digitalized, healthcare providers are seeking professional services including consulting, system integration, training, and technical support to maximize the value of their OIS investments. Vendors are offering managed services, cloud migration assistance, and analytics consulting to help providers optimize workflows, ensure regulatory compliance, and improve system ROI. The demand for end-to-end service offerings is particularly high among new cancer care centers and institutions transitioning to value-based care models.
Medical Oncology accounted for the largest share of the Oncology Information Systems market due to the rising global burden of cancers requiring pharmacological treatment, including chemotherapy, immunotherapy, and targeted therapies. Managing complex medication regimens, documenting adverse events, and tracking therapy responses necessitates robust OIS platforms. Systems specifically designed for medical oncology help oncologists personalize treatments, monitor side effects, and adjust protocols dynamically based on patient outcomes.
The growing availability of novel cancer therapies, such as checkpoint inhibitors and CAR-T cell therapies, is further intensifying the need for sophisticated information management systems to handle increasingly personalized, data-intensive treatment plans.
On the other hand, Radiation Oncology is emerging as the fastest-growing application area. Advances in radiation therapy technologies, such as proton therapy, stereotactic body radiation therapy (SBRT), and image-guided radiation therapy (IGRT), require precise planning, documentation, and outcome tracking. Radiation oncology OIS modules assist in generating and modifying complex treatment plans, integrating imaging data, and ensuring radiation safety protocols. The increasing number of cancer centers installing state-of-the-art radiation therapy equipment is boosting demand for specialized radiation oncology information systems.
North America, particularly the United States, holds the largest share of the Oncology Information Systems market. The region’s dominance can be attributed to factors such as the high prevalence of cancer, well-established healthcare infrastructure, favorable reimbursement policies, widespread adoption of health IT solutions, and supportive regulatory frameworks like the Health Information Technology for Economic and Clinical Health (HITECH) Act.
Major players like Varian Medical Systems (now part of Siemens Healthineers), Elekta, and Cerner Corporation have a strong presence in North America, further consolidating the region’s leadership. Additionally, initiatives such as the U.S. Cancer Moonshot and the growing adoption of value-based care models are driving the demand for advanced oncology information management systems.
Asia-Pacific is emerging as the fastest-growing region in the OIS market, fueled by rising cancer incidence, expanding healthcare investments, improving digital infrastructure, and government initiatives to enhance cancer care. Countries like China, India, Japan, South Korea, and Australia are experiencing a surge in demand for oncology IT solutions as they modernize their healthcare systems and address large patient populations.
The increasing establishment of cancer specialty hospitals, the growing adoption of cloud-based healthcare IT solutions, and favorable regulatory reforms (such as India's National Digital Health Mission) are catalyzing OIS market growth across the region.
Key companies are primarily focused on incorporating technological innovation with the introduction of web-based oncology solutions and Artificial Intelligence (AI)-based OIS solutions with a goal to enhance the treatment regime, thereby expected to positively impact the market growth in the near future. Some of the key market players operating in the global oncology information systems market include:
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Oncology Information Systems market.
By Product
By Application
By End User
By Region
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers